Aposense Information

Aposense is an innovative biotechnology company that developed a transformational delivery technology for macromolecules. The pioneering technology, named Molecular Nano-Motors (MNMs), is based on a novel mechanism that leverages membrane electrical forces, facilitating entry of charged molecules into cells. With this technology new treatment options become available for a wide range of diseases using difficult to deliver molecules such as oligonucleotide-based drugs (siRNA, ASO). Equipped with full capacity research facilities and working with leading research organizations, its team of seasoned scientists has demonstrated the therapeutic potential of the MNM technology in numerous preclinical studies with Phase I study planned for later this year. Aposense’s innovative spirit and scientific excellence has been recognized by key opinion leaders in the pharma industry and by non-governmental organizations (NGO) such as the Bill & Melinda Gates Foundation.